Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Historic Crypto Crash Aftermath: Binance’s $400M Payout Plan to “Rekt” Traders

Historic Crypto Crash Aftermath: Binance’s $400M Payout Plan to “Rekt” Traders

Biggest Crash on Record Jolts Crypto Markets Cryptocurrency markets were roiled by an unprecedented crash on Oct. 10–11, 2025, sparked by geopolitical shock. On Oct. 10, former U.S. President Donald Trump stunned markets by threatening 100% tariffs on Chinese imports, reigniting trade-war fears ts2.tech. Investors fled risk assets en masse, triggering a flash crash across crypto markets. Within hours, Bitcoin collapsed ~16%, tumbling from around $125,000 to lows near $104,000 coinspeaker.com. Major altcoins plunged even further – Ethereum fell from ~$4,500 to the mid-$3,000s (−15–20%), while many smaller coins nosedived 30–80% in the panic selling ts2.tech. As one outlet summarized,
16 October 2025
MercadoLibre Stock Slides Amid Fintech Boom – Analysts Predict Big 2025 Comeback

MercadoLibre Stock Slides Amid Fintech Boom – Analysts Predict Big 2025 Comeback

Stock Volatility in October MercadoLibre’s stock (NASDAQ: MELI) has seen significant swings in recent days. After trading as high as ~$2,500 per share in late September – near its 52-week peak – the stock stumbled through early October amid global tech volatility and Latin American market jitters ts2.tech. On October 15, shares opened around $2,182 but plunged over 5% intraday to roughly $2,048 ts2.tech, before stabilizing near the low $2,100s. This slide continued a pullback from the late-September highs and put the stock about 10–15% below its recent peak ts2.tech. Even with the October dip, MercadoLibre is still modestly positive
16 October 2025
iRobot Stock Skyrockets 55% in Short-Squeeze Frenzy – Bubble or Breakout?

iRobot Stock Skyrockets 55% in Short-Squeeze Frenzy – Bubble or Breakout?

IRBT Stock Soars on Short-Squeeze Rally iRobot’s stock price skyrocketed this week in one of its sharpest moves on record. On Wednesday (Oct. 15), IRBT jumped from $3.93 to about $5.37 at the close, a +36% gain in one day stocktwits.com. Intra-day, the Roomba maker’s stock hit $6.09 (a level last seen in March) before paring back ts2.tech. By comparison, major indexes were flat to mildly positive that day ts2.tech – making iRobot a dramatic outlier. The sudden spike pushed IRBT well above its recent trading range (the stock had languished under $4 for weeks) and lifted shares to a
16 October 2025
Sana Biotechnology (SANA) Stock Skyrockets on ‘100-Bagger’ Hype – Experts Debate What’s Next

Sana Biotechnology (SANA) Stock Skyrockets on ‘100-Bagger’ Hype – Experts Debate What’s Next

Surge Fueled by a ‘100-Bagger’ Tweet Sana Biotechnology’s stock skyrocketed mid-week after a bold endorsement from a well-known tech investor. On Oct. 15, SANA shares jumped over 25% in a single session, closing at $5.62 (up from $4.45 the day prior) ts2.tech. In intraday trading the stock even hit roughly $6.55 before paring back gains ts2.tech. The catalyst? A viral post on social media. Hedge fund manager Eric Jackson — known for spotting high-growth plays — proclaimed on X (formerly Twitter) that “Biotech is back… $SANA looks like the next 100-bagger platform”. He pointed to an improving macro backdrop (lower
Uranium Royalty Stock Soars on Nuclear Boom – UROY Hits New High, What’s Next?

Uranium Royalty Stock Soars on Nuclear Boom – UROY Hits New High, What’s Next?

UROY Stock Blasts Off Amid Uranium Market Revival Uranium Royalty Corp’s stock price has been on a tear, riding a wave of optimism in the nuclear energy sector. On October 15, UROY spiked intraday to about $4.87 per share, its highest level in a year Marketbeat. It closed that session up over 11% at roughly $4.75 Finviz – capping a stunning rally in recent months. Just a year ago UROY traded near $2.50; it has since doubled in value, now sitting ~85% higher than 12 months prior Finviz. Over 116% of those gains have come in 2025 alone as the
16 October 2025
Adaptimmune (ADAP) Sees Wild Stock Surge Amid Cash Crunch – Biotech Turnaround or Last Gasp?

Adaptimmune (ADAP) Sees Wild Stock Surge Amid Cash Crunch – Biotech Turnaround or Last Gasp?

Stock Price Rollercoaster in 2025 Adaptimmune’s stock has been on a wild ride this year, with extreme price swings in recent weeks grabbing headlines. After languishing in penny-stock territory for months, ADAP suddenly caught fire in late September 2025. On September 19, shares opened at a mere $0.08 but skyrocketed 98% by day’s end to $0.16, then jumped another 30% after-hours to ~$0.20 ts2.tech. This stunning one-day move – without any company-specific catalyst – was accompanied by an enormous volume of 705+ million shares traded (versus ~60 million on an average day) ts2.tech. Market observers noted Adaptimmune as one of
16 October 2025
Nancy Pelosi & Warren Buffett Are Both Betting on These 4 Stocks — What Do They Know?

Nancy Pelosi & Warren Buffett Are Both Betting on These 4 Stocks — What Do They Know?

Pelosi & Buffett’s $Billion Stock Overlap: Tech Titans and Financial Giants It’s not often that the “Oracle of Omaha” (Buffett) and a prominent Washington figure (Pelosi) end up betting on the same horses. Yet recent disclosures reveal four stocks common to both their portfolios Benzinga. Amazon and Apple form the tech half of this overlap, while Visa and American Express form the finance half. In summary: these four shared stocks suggest that despite very different investing styles, Pelosi and Buffett are finding common ground in companies with dominant market positions and long-term growth stories. Their overlap spans two industries –
Silver Hits All-Time High Above $53 and Gold Tops $4,200 – Why Prices Are Soaring

Silver Hits All-Time High Above $53 and Gold Tops $4,200 – Why Prices Are Soaring

Precious Metals Surge to Historic Highs Gold and silver prices are shattering records as anxious investors rush into safe-haven assets. This week, spot gold blew past the $4,200/oz milestone for the first time ever reuters.com, extending a remarkable rally that’s seen it gain over 60% so far this year reuters.com. Gold has now notched five consecutive sessions of gains, peaking around $4,243 on Thursday morning (Oct. 16) reuters.com. Its sister metal silver has been on an even more spectacular tear: spot silver hit $53.60/oz on Tuesday – a new all-time high, finally surpassing the long-standing 1980 and 2011 peaks reuters.com.
16 October 2025
Redwire (RDW) Shares Plummet on Shake-Up – Is a Takeoff Next?

Redwire (RDW) Shares Plummet on Shake-Up – Is a Takeoff Next?

Redwire (NASDAQ:RDW) closed about $9.40 on Oct 15, down ~1.5% on the day investing.com (after a 5.3% pop on Oct 14). The stock is volatile: it fell ~9.4% in one day and ~18.6% over a week after recent corporate news ts2.tech. Year-to-date, RDW is still down ~42% (despite a 12.8% one-year gain) ts2.tech. Major catalysts include a new Oct 14 partnership with Red Cat to pair Redwire’s Stalker drone with Red Cat’s Black Widow quadcopter businesswire.com, a Sept 25 contract to supply solar arrays for Axiom Space’s station module, and the Aug launch of SpaceMD, Redwire’s new pharmaceutical subsidiary (commercializing
15 October 2025
HOVR Stock Rockets as Horizon Aircraft Lands Pratt & Whitney Engine Partnership

HOVR Stock Rockets as Horizon Aircraft Lands Pratt & Whitney Engine Partnership

Hybrid eVTOL Progress and Forecast New Horizon Aircraft is focused on certifying and producing its Cavorite X7, a 7-seat hybrid-electric VTOL aircraft. The company envisions a first flight-worthy prototype within ~18 months and full production by the late-2020s. CEO Brandon Robinson said the successful May 2025 test flight “was already an incredible year for the technical team,” and now they are pushing toward full-scale design completion Verticalmag. Horizon notes it has the cash runway and partnerships (with Pratt & Whitney, government agencies, etc.) to achieve these goals Sec Sec. Financially, Horizon remains pre-revenue. Its Q1 FY2026 report (Aug–Oct 2025) did
Rocket Lab (RKLB) Stock Blasts Off: Japan Launch Deals and Analyst Upgrades Fuel 700% Rally

Rocket Lab (RKLB) Stock Blasts Off: Japan Launch Deals and Analyst Upgrades Fuel 700% Rally

Stock Price and Market Momentum Rocket Lab shares have been on a tear. As of mid-day Oct. 15, 2025, RKLB was trading around $72 per share (up about 6.8% on the day) Stockanalysis. The stock closed at about $68.03 on Oct. 14 (up ~4% that day) Investing, extending a multi-week rally. Over the past year the shares are roughly 7× higher, and they regularly hit new highs – for example jumping ~7% to about $66 on Oct. 8 ts2.tech. Today’s price is well above the 50-, 100- and 200-day moving averages Benzinga and is within striking distance of its 52-week
Recursion RXRX Stock Skyrockets: AI Breakthroughs and Big Pharma Deals Ignite Biotech Surge

Recursion RXRX Stock Skyrockets: AI Breakthroughs and Big Pharma Deals Ignite Biotech Surge

Volatile Stock Performance in October 2025 Recursion’s stock showed wild swings in early October. On Oct 7, 2025 the shares fell about 5.4% to ~$5.23 amid a broad market slump nasdaq.com. The very next day (Oct 8) the stock rebounded sharply, jumping roughly 16% to ~$6.08 ts2.tech. This put RXRX near the middle of its 52-week trading range (about $3.97–$10.87) ts2.tech. Trading volume on these moves was heavy, with tens of millions of shares changing hands as investors positioned for upcoming company news. By Oct 14, RXRX was around $5.89 stocktitan.net. This volatility appears driven by renewed enthusiasm for Recursion’s
Nokia Stock Surges on 5G Deals and Bullish Forecasts – What’s Next for NOK Investors?

Nokia Stock Surges on 5G Deals and Bullish Forecasts – What’s Next for NOK Investors?

Sources: Market quotes and technical data from Reuters reuters.com investing.com; Nokia financials and analyst data from MarketBeat marketbeat.com marketbeat.com; Nokia corporate news (deals, share issuance) from company releases and RTTNews nasdaq.com nasdaq.com; industry developments from Reuters and TelecomTV reuters.com reuters.com telecomtv.com ts2.tech; forecasts and expert comments from Reuters and investing analysis reuters.com reuters.com investing.com.
15 October 2025
NuScale’s Stock Skyrockets on 6GW SMR Deal – Is GE Vernova Missing Out?

NuScale’s Stock Skyrockets on 6GW SMR Deal – Is GE Vernova Missing Out?

Analysts Weigh In Analysts note that SMR’s recent rally reflects both real progress and speculative fervor. On one hand, NuScale’s NRC approvals and partnerships set it up as an industry leader Finviz ts2.tech. In early October, NuScale shares even spiked +5% when Italy’s government moved to reintroduce nuclear power with “modular” reactors Nasdaq Nasdaq. On the other hand, NuScale still loses money (burning ~$95M cash per quarter as of mid-2025) and faces stiff competition Nasdaq Finviz. The Zacks report notes NuScale has underperformed peers recently (SMR +12.7% in 3 months vs. GE Vernova +17.6%, NanoNuclear +35%) Finviz. It warns that
Canadian Solar (CSIQ) Stock Skyrockets: Analyst Upgrade & Battery Boom Ignite Rally

Canadian Solar (CSIQ) Stock Skyrockets: Analyst Upgrade & Battery Boom Ignite Rally

Stock Rally and Analyst Buzz Canadian Solar’s stock has surged sharply this week. On Oct 14 its share price hit a 52-week high of around $16.00 before closing at $15.72 Marketbeat. This spike was driven by two main headlines: Goldman Sachs unexpectedly raised its CSIQ price target on Oct 9 (boosting investor confidence, even as Goldman still left a “sell” rating Marketbeat), and news out of China about planned cuts to solar panel capacity (seen as reducing supply gluts). Indeed, Reuters reports that Chinese regulators may soon clamp down on excess PV manufacturing, which sent Chinese solar stocks soaring on
Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Deal Details: Novo Licenses Omeros’s MASP-3 Inhibitor On Oct. 15, Novo Nordisk and Seattle-based Omeros announced a definitive asset purchase and license agreement. Under the terms, Novo gains exclusive global rights to zaltenibart (OMS906) for all indications. Omeros will receive $340 million up front and near-term milestones, plus up to $2.1 billion total with development and sales milestones and tiered royalties Novonordisk. Reuters reported Novo would pay “up to $2.1 billion” for the experimental drug Reuters. The deal is structured as a licensing asset purchase, not a full acquisition, and is expected to close in Q4 2025 Marketscreener Novonordisk. Novo’s Chief Scientific
Synchrony Financial Stock Surges on Blowout Q3 Earnings and $1B Buyback Plan

Synchrony Financial Stock Surges on Blowout Q3 Earnings and $1B Buyback Plan

Synchrony Financial’s stock has rallied on these strong fundamentals. After closing near $72.84 on Oct. 14, shares ticked up in early trading on Oct. 15 (around $74) as investors digested the blowout results reuters.com marketbeat.com. The company’s Q3 beat was driven by tighter credit management and robust online spending, giving shareholders confidence. “Synchrony’s third-quarter performance was highlighted by a return to purchase volume growth… and continued strength in our credit performance,” said CEO Brian Doubles benzinga.com, echoing industry-wide trends of healthy consumer payments. The earnings report showed earnings per share of $2.86, well above the $2.22 analysts expected marketbeat.com finimize.com.
Power Outage Paralyzes PATCO Trains: Thousands of Philadelphia Commuters Stranded

Power Outage Paralyzes PATCO Trains: Thousands of Philadelphia Commuters Stranded

Transit Shutdown: What Happened This Morning Philadelphia’s regional PATCO Speedline (operated by the DRPA) sputtered to a halt at the worst possible time – the Wednesday morning commute. At about 8:30 a.m., PATCO announced all trains were suspended due to a power failure linked to PSE&G inquirer.com fox29.com. (“PSE&G” is the New Jersey utility that supplies electricity to the line.) By 8:35 a.m. news outlets like NBC10 and FOX29 confirmed the shutdown, noting there was no timetable for service restoration inquirer.com fox29.com. PATCO (which carries roughly 34,000 riders per weekday patch.com) said crews were on site but could not say when trains
15 October 2025
Humana Hit Hard: Judge Upholds Medicare Advantage Star Cut, Stock Slides

Humana Hit Hard: Judge Upholds Medicare Advantage Star Cut, Stock Slides

Lawsuit Outcome and Court Ruling Humana (the second‐largest Medicare Advantage insurer) sued CMS in July after its star rating unexpectedly plunged. The insurer argued that CMS unfairly flagged three interpreter calls as failures (with no callback allowed), causing a 4.5-to-3.5 star drop reuters.com healthcaredive.com. On Oct. 14, U.S. District Judge Reed O’Connor (Northern Texas) rejected Humana’s arguments reuters.com. He found that CMS had acted “in accordance with its guidelines” and did not act arbitrarily fiercehealthcare.com. In particular, the judge upheld CMS’s no-callbacks policy for those language-line test calls as lawful healthcaredive.com. The case was dismissed “with prejudice,” meaning Humana can’t
15 October 2025
1 77 78 79 80 81 140

Stock Market Today

L’Oreal share price slips into weekend as OR.PA heads for annual results test

L’Oreal share price slips into weekend as OR.PA heads for annual results test

7 February 2026
Paris, Feb 7, 2026, 22:06 (CET) — Market closed. L’Oréal S.A. shares ended Friday slightly lower at 394.05 euros, as traders headed into the weekend with the French cosmetics group’s annual results just days away. The next session in Paris is Monday, and positioning tends to get jumpy ahead of a big print, especially for large, “defensive” consumer names that many funds hold for stability. Europe’s earnings season has been messy, but investors are still looking for clean signals on pricing power and demand from global exporters. LSEG I/B/E/S data showed analysts still expect a drop in fourth-quarter 2025 earnings
RBC stock heads into new week near C$233 after Canada jobs surprise

RBC stock heads into new week near C$233 after Canada jobs surprise

7 February 2026
Royal Bank of Canada shares closed Friday up 0.7% at C$232.72, trailing gains by other major Canadian banks. Canada’s main stock index surged 1.5% as metals rebounded. January jobs data showed a loss of 24,800 positions but a lower 6.5% unemployment rate. RBC’s Q1 earnings are due Feb. 26.
IHC stock price holds near 400 dirhams after Abu Dhabi group flags phishing emails

IHC stock price holds near 400 dirhams after Abu Dhabi group flags phishing emails

7 February 2026
International Holding Company PJSC warned investors of phishing scams using its name and logo, according to an ADX disclosure. IHC shares closed flat at 399.60 dirhams on Friday, trading in a narrow range with 237,109 shares changing hands. UAE equities ended the week slightly higher as traders watched Iran-U.S. talks and oil prices.
Go toTop